ReWalk Robotics Announces Closing of $40.0 Million Private Placement Priced At-the-Market
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 26, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its
previously announced private placement of 10,921,502 ordinary shares and warrants to purchase up to 5,460,751 ordinary shares, at a purchase price of $3.6625 per share and associated warrant, that
was priced “at-the-market” under Nasdaq rules and resulted in gross proceeds of approximately $40.0 million before the deduction of placement agent fees and expenses and estimated offering expenses
payable by the Company. The warrants have a term of five and one-half years, are exercisable immediately and have an exercise price of $3.60 per ordinary share.
H.C. Wainwright & Co., LLC acted as the sole placement agent for the offering.
The Company intends to use the net proceeds for: (i) sales, marketing and reimbursement expenses related to market development activities of its ReStore and Personal 6.0 devices, broadening third-party payor and CMS coverage for its ReWalk Personal device and commercializing its new product lines added through distribution agreements; (ii) research and development of its lightweight exo-suit technology for potential home personal health utilization for multiple indications and future generation designs for its spinal cord injury device; (iii) routine product updates; and (iv) general corporate purposes, including working capital needs.
The offer and sale of the foregoing securities were made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.
Under an agreement with the investors, the Company is required to file an initial registration statement with the Securities and Exchange Commission (the “SEC”) covering the resale of the ordinary shares to be issued to the investors (including the shares underlying the warrants) no later than March 11, 2021 and to use best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than May 20, 2021 in the event of a “full review” by the SEC.